GE HealthCare Japan Launches New Version of Venue™ Ultrasound Series with AI Features

April 22, 2026

GE HealthCare Japan (Headquarters: Hino City, Tokyo; President & CEO: Shinichi Matsuoka), a healthcare company dedicated to solving medical challenges, will begin selling new versions of its Point of Care (POC) ultrasound diagnostic devices—Venue™, Venue Go™, and Venue Fit™—equipped with AI functions starting April 22 in Japan.

The Venue™ series was developed for use in POC ultrasound examinations such as emergency medicine, intensive care, operating rooms, orthopedics, and dialysis. The new versions launched today feature applications utilizing AI technology to alleviate the burden on healthcare professionals and aim for further improvement in examination efficiency. High-quality ultrasound images and intuitive operability remain consistent while supporting the delivery of high-quality examinations.

[Main New Features and Characteristics]

1. AI Tool 'Nerveblox' Effectively Supports Nerve Block Procedures
Developed using AI, Nerveblox is a function that recognizes and highlights nerves and surrounding tissues (muscles, blood vessels, bones, fascia, etc.) in real-time for 12 standard nerve block sites used in regional anesthesia. It includes features like Quality Meter to evaluate image quality, Orientation display to guide probe direction, Color Overlay for tissue color-coding, Anatomical Labeling, and a schematic guide for ideal probe placement. This supports stable nerve visualization regardless of the operator's echo experience level, improving visibility and judgment in anesthesia, emergency, ICU, and orthopedics.

2. AI Tool 'Auto Bladder Volume' Streamlines Bladder Assessment
Auto Bladder Volume is a semi-automated measurement tool developed with AI. It automatically recognizes bladder shape and calculates volume from cross-sectional and longitudinal images, enabling highly reproducible evaluations. This is expected to be useful in emergency departments, ICUs, post-surgery, and wards, allowing for rapid and efficient bladder volume assessment without invasive procedures.

3. AI Tool 'AFI' (Automated Function Imaging) Enables Easier Cardiac Function Evaluation
Developed with AI, AFI uses 2D speckle tracking technology to automatically track and visualize myocardial wall motion for quantitative analysis. It enables color map displays based on myocardial contraction and simultaneously calculates the Ejection Fraction (EF) using the Simpson method. Previously found only on high-end cardiovascular ultrasound systems, this feature is now available in the POC domain, allowing for simple yet high-precision cardiac function analysis in various settings.

About GE HealthCare Japan
GE HealthCare Japan Co., Ltd. was established in 1982 as one of GE HealthCare's core global hubs. It covers everything from prevention to diagnosis, treatment, follow-up, and prognosis management, aiming for 'Precision Care.'